These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 893592)

  • 21. Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazid.
    Perry TL; Kish SJ; Hansen S; Wright JM; Wall RA; Dunn WL; Bellward GD
    J Neurochem; 1981 Jul; 37(1):32-9. PubMed ID: 7252511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line.
    Sanfeliu C; Wright JM; Kim SU
    Neurotoxicology; 1999 Dec; 20(6):935-44. PubMed ID: 10693974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo.
    Timbrell JA; Mitchell JR; Snodgrass WR; Nelson SD
    J Pharmacol Exp Ther; 1980 May; 213(2):364-9. PubMed ID: 6767840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of the isoniazid metabolite monoacetylhydrazine in urine by high-performance liquid chromatography.
    Jenner PJ; Ellard GA
    J Chromatogr; 1987 Mar; 415(1):188-96. PubMed ID: 3584356
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the role of acetylhydrazine in isoniazid hepatotoxicity.
    Timbrell JA
    Arch Toxicol Suppl; 1979; (2):1-8. PubMed ID: 288324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of acetylator phenotype based on the ratio of acetylisoniazid to isoniazid in urine following an oral dose of ordinary isoniazid.
    Raghupati Sarma G; Kannapirin G; Narayana AS; Radhakrishna S; Tripathy SP
    Indian J Med Res; 1976 Jan; 64(1):1-8. PubMed ID: 1270091
    [No Abstract]   [Full Text] [Related]  

  • 27. [Determination of isoniazid and acetylisoniazid in the urine for phenotyping isoniazid inactivators].
    Yan DX
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1983 Apr; 6(2):71-3. PubMed ID: 6628126
    [No Abstract]   [Full Text] [Related]  

  • 28. Acetylation phenotyping of isoniazid using a simple and accurate high-performance liquid chromatography.
    el-Sayed YM; Islam SI
    J Clin Pharm Ther; 1989 Jun; 14(3):197-205. PubMed ID: 2760118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and quantitation of hydrazine in the urine of patients treated with hydralazine.
    Timbrell JA; Harland SJ
    Clin Pharmacol Ther; 1979 Jul; 26(1):81-8. PubMed ID: 445966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of two metabolites of isoniazid (isonicotinoylglycine and 1-isonicotinoyl-2-acetylhydrazine) by paper chromatography in rat urine.
    DEFRANCESCHI A; ZAMBONI V
    Biochim Biophys Acta; 1954 Feb; 13(2):304-5. PubMed ID: 13140337
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of rifampicin on pharmacokinetics of isoniazid and its metabolite acetylhydrazine in rats.
    Zhang RL; Wang ZY; Li D; Cheng WB
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):494-6. PubMed ID: 1302435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The determination of isoniazid and its metabolites in human urine.
    Peters JH; Miller KS; Brown P
    Anal Biochem; 1965 Aug; 12(2):379-94. PubMed ID: 5874886
    [No Abstract]   [Full Text] [Related]  

  • 34. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorometric determination of isoniazid and its metabolites in urine by high-performance liquid chromatography using in-line derivatization.
    Kohno H; Kubo H; Furukawa K; Yoshino N; Nishikawa T
    Ther Drug Monit; 1991 Sep; 13(5):428-32. PubMed ID: 1957336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ion-pair high-performance liquid chromatographic determination of isoniazid and acetylisoniazid in plasma and urine. Application for acetylator phenotyping.
    Svensson JO; Muchtar A; Ericsson O
    J Chromatogr; 1985 May; 341(1):193-7. PubMed ID: 4019685
    [No Abstract]   [Full Text] [Related]  

  • 37. Is isoniazid-hepatotoxicity induced by the metabolite, hydrazine?
    Noda A; Hsu KY; Noda H; Yamamoto Y; Kurozumi T
    J UOEH; 1983 Jun; 5(2):183-90. PubMed ID: 6679629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous quantitation of hydrazine and acetylhydrazine in human plasma by high performance liquid chromatography-tandem mass spectrometry after derivatization with p-tolualdehyde.
    Song L; Gao D; Li S; Wang Y; Liu H; Jiang Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1063():189-195. PubMed ID: 28881295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A high pressure liquid chromatography method for detecting the isoniazid derivative isonicotinoyl-hydrazine sodium glucuronide, free isoniazid and acetylisoniazid and its use in pharmacologic studies].
    Musch E; Lütjohann D; Peter MG; Schwabe HK
    Pneumologie; 1990 Feb; 44 Suppl 1():490-2. PubMed ID: 2367446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylator phenotype and metabolic disposition of isoniazid in Japanese patients with systemic lupus erythematosus.
    Ishizaki T; Horai Y; Koya G; Matsuyama K; Iguchi S
    Arthritis Rheum; 1981 Oct; 24(10):1245-54. PubMed ID: 7306226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.